News

A preprint study from Yale University researchers examined a condition known as post-vaccination syndrome. The study included 42 individuals with PVS and 22 without. Researchers observed elevated levels of spike proteins in the PVS group for 36 to 709 days because the time that lapsed since the last vaccination varied between participants. It is a…Continue reading Yale Study Finds Post-Vaccine Syndrome Shares Symptoms with Long COVID

A Georgia jury has ruled against Bayer in which a plaintiff claimed his use of Roundup caused his non-Hodgkin’s Lymphoma. The nearly $2.1 billion verdict is the largest payout the biotechnology company has paid out, as 60,000 lawsuits are still pending. The verdict includes $65 million in compensatory damages and $2 billion in punitive damages.…Continue reading Jury Slams Bayer With Nearly $2.1B Verdict Over Glyphosate Cancer Claims

HHS Secretary Robert F. Kennedy Jr. paused a clinical trial funded by the Biomedical Advanced Research and Development Authority (BARDA) for a COVID-19 oral vaccine made by Vaxart. Kennedy said, “While it is crucial that the Department [of] Health and Human Services (HHS) support pandemic preparedness, four years of the Biden administration’s failed oversight have…Continue reading RFK Jr. Halts COVID-19 Oral Vaccine Trial for 90 Days, Ends Flu Vaccine Ad Campaign

The genetic data of 15 million people will soon be for sale as 23andMe has filed for Chapter 11 bankruptcy. The attorneys general for California and New York issued consumer alerts to advise consumers to take action to protect their data. New York AG Rob Bonta said “There’s health insurance companies that are interested in…Continue reading 23andMe Files for Chapter 11 Bankruptcy; Genetic Data of 15 Million Users at Risk of Sale

Bayer continues to face struggles related to its acquisition of Monsanto and the flagship product Roundup, which currently has 67,000 pending cases alleging the herbicide has caused serious health conditions. So far, Bayer has paid out $10 billion to settle cases and has $5.9 billion set aside to resolve the pending cases. Sources told Reuters…Continue reading Bayer Seeks Capital Raise to Cover Roundup Lawsuit Settlements

Dr. Peter Marks, an FDA official involved in Operation Warp Speed, has resigned from his position as director of the Center for Biologics Evaluation and Research (CBER). Marks started his career at the FDA as deputy director of the CBER in 2012 and has been the director since 2016. CBER is tasked with ensuring biological…Continue reading Peter Marks Resigns From FDA As HHS Fires 10,000 Employees In Reorganization Effort